Molecular-Guided Surgery for Pancreatic and Gastrointestinal Neuroendocrine Cancers
Latest Information Update: 18 Sep 2023
At a glance
- Drugs Gallium 68-DOTATATE (Primary)
- Indications Gastrointestinal cancer; Neuroendocrine carcinoma; Pancreatic cancer
- Focus Diagnostic use
- 06 Sep 2023 Status changed from recruiting to withdrawn prior to enrolment.
- 24 Aug 2021 Planned End Date changed from 7 Jun 2021 to 7 Jun 2023.
- 24 Aug 2021 Planned primary completion date changed from 7 Jun 2021 to 7 Jun 2022.